Compugen Discloses Lead Therapeutic Candidate for CGEN-15029 Immuno-Oncology Program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Oil edges higher as investors weigh renewed Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
| Compugen Ltd (NASDAQ: CGEN) | Delayed: 1.97 +0.01 (0.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.96 | 52 Week High | $7.79 | |||
| Open | $1.97 | 52 Week Low | $4.32 | |||
| Day High | $2.00 | P/E | N/A | |||
| Day Low | $1.95 | EPS | $-0.36 | |||
| Volume | 129,008 | |||||
